共 101 条
[71]
Mykletun A., Dahl A.A., Haaland C.F., Bremnes R., Dahl O., Klepp O., Wist E., Fossa S.D., Side-effects and cancer-related stress determine quality of life in long-term survivors of testicular cancer, J Clin Oncol, 23, pp. 3061-8, (2005)
[72]
Oldenburg J., Sm K., Cvancarova M., Lothe R.A., Fossa S.D., Cisplatin-induced long-term hearing impairment is associated with specific glutathione s-transferase genotypes in testicular cancer survivors, J Clin Oncol, 25, pp. 708-14, (2007)
[73]
Tannock I.F., Ahles T.A., Ganz P.A., Van Dam F.S., Cognitive impairment associated with chemotherapy for cancer: Report of a workshop, J Clin Oncol, 22, pp. 2233-9, (2004)
[74]
Bradley J., Graham M.V., Winter K., Purdy J.A., Komaki R., Roa W.H., Ryu J.K., Bosch W., Emami B., Toxicity and outcome results of RTOG 9311: A phase I-II dose-escalation study using three-dimensional conformal radiotherapy in patients with inoperable non-small-cell lung carcinoma, Int J Radiat Oncol Biol Phys, 61, pp. 318-28, (2005)
[75]
Stensvold E., Aass N., Gladhaug I., Stenwig A.E., Claussen O.P., Fossa S.D., Erroneous diagnosis of pancreatic cancer after radiotherapy of testicular cancer, Eur J Surg Oncol, 30, pp. 352-5, (2004)
[76]
Maduro J.H., Pras E., Willemse P.H.B., De Vries E.G.E., Acute and long-term toxicity following radiotherapy alone or in combination with chemotherapy for locally advanced cervical cancer, Cancer Treat Rev, 29, pp. 471-88, (2003)
[77]
Green J., Kirwan J., Tierney J., Vale C., Symonds P., Fresco L., Williams C., Collingwood M., Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix, Cochrane Database Syst Rev, 20, 3, (2005)
[78]
Lundby L., Krogh K., Jensen V.J., Gandrup P., Qvist N., Overgaard J., Laurberg S., Long-term anorectal dysfunction after postoperative radiotherapy for rectal cancer, Dis Colon Rectum, 45, pp. 1343-9, (2005)
[79]
Dearnaley D.P., Sydes M.R., Graham J.D., Aird E.G., Bottomley D., Cowan R.A., Huddart R.A., Jose C.C., Matthews J.H., Millar J., Et al., Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: First results from the MRC RT01 randomised controlled trial, Lancet Oncol, 8, pp. 475-87, (2007)
[80]
Carver J.R., Shapiro C.L., Ng A., Jacobs L., Schwartz C., Virgo K.S., Hagerty K.L., Somerfield M.R., Vaughn D.J., ASCO Cancer Survivorship Expert Panel, J Clin Oncol, 25, pp. 3991-4008, (2007)